These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [SOME PROBLEMS OF THE ANTICOAGULANT TREATMENT OF DEEP VENOUS THROMBOSIS IN PREGNANCY]. FORGACS J; NEMETH L Orv Hetil; 1964 Jun; 105():1162-5. PubMed ID: 14160767 [No Abstract] [Full Text] [Related]
4. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS]. IAROSHEVSKII AIa; ZHAVORONKOVA EK Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441 [No Abstract] [Full Text] [Related]
6. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II. KAZMIER F; SPITTELL JA; THOMPSON JJ; OWEN CA Arch Intern Med; 1965 Jun; 115():667-73. PubMed ID: 14299436 [No Abstract] [Full Text] [Related]
7. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)]. Migne J; Monteil R; Pessereau G; Pernod J; Siau J Therapie; 1968; 23(3):553-66. PubMed ID: 5740621 [No Abstract] [Full Text] [Related]
8. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY? SAMUELSSON SM; LILIENBERG G Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757 [No Abstract] [Full Text] [Related]
9. ["COAGULANT" FRACTIONS CONTAINING COAGULATION FACTORS ADSORBABLE BY TRICALCIC PHOSPHATE]. SOULIER JP; BLATRIX C; STEINBUCH M Presse Med (1893); 1964 Apr; 72():1223-8. PubMed ID: 14134215 [No Abstract] [Full Text] [Related]
10. EFFECTS OF FIBRINOLYTIC AGENTS AND HEPARIN ON BLOOD COAGULATION IN DOGS. LEWIS JH; SHIRAKAWA M Am J Physiol; 1964 Nov; 207():1049-52. PubMed ID: 14237448 [No Abstract] [Full Text] [Related]
12. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY. HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902 [No Abstract] [Full Text] [Related]
13. PLASMA THROMBOPLASTIN COMPONENT (PTC) DEFICIENCY: A CASE REPORT. IDA M; TANAKA M Shonika Kiyo; 1963; 9():297-301. PubMed ID: 14112922 [No Abstract] [Full Text] [Related]
14. CONTROLLED STUDY OF THE EFFECTIVE LEVEL OF LONG-TERM ANTICOAGULATION. MOSCHOS CB; WONG PC; SISE HS JAMA; 1964 Nov; 190():799-805. PubMed ID: 14202822 [No Abstract] [Full Text] [Related]
15. HYPERCOAGULABILITY OF BLOOD AFTER BURN TRAUMA IN RATS. A PRELIMINARY REPORT. ARTURSON G; WALLENIUS G Acta Chir Scand; 1964 Oct; 128():340-5. PubMed ID: 14211288 [No Abstract] [Full Text] [Related]
17. ANTICOAGULANT THERAPY; APPRAISAL OF ITS LABORATORY CONTROL. WARE AG; STERLING RE; STRAGNELL R Angiology; 1964 Jan; 15():11-6. PubMed ID: 14104834 [No Abstract] [Full Text] [Related]
18. THROMBOPLASTIC ACTIVITY OF HUMAN SALIVA IN PATIENTS UNDER PROLONGED ANTICOAGULATION THERAPY. DOKU HC; TAYLOR RG; SISE HS; BECKER R J Dent Res; 1964; 43():323-30. PubMed ID: 14159035 [No Abstract] [Full Text] [Related]
19. [Effect of various laboratory tests in the control of anticoagulant therapy]. Molinas FC; Sanchez Avalos JC Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645 [No Abstract] [Full Text] [Related]
20. SURVIVAL TIME OF PROTHROMBIN AND FACTORS VII, IX AND X AFTER COMPLETELY SYNTHESIS BLOCKING DOSES OF COUMARIN DERIVATIVES. HELLEMANS J; VORLAT M; VERSTRAETE M Br J Haematol; 1963 Oct; 9():506-12. PubMed ID: 14076133 [No Abstract] [Full Text] [Related] [Next] [New Search]